Recent EVAX News
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 11/21/2025 01:43:30 PM
- Evaxion Biotech jumps over 10% after AI engine uncovers new CMV vaccine targets • IH Market News • 11/20/2025 03:47:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/20/2025 01:15:04 PM
- Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1 • GlobeNewswire Inc. • 11/20/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/18/2025 04:00:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/12/2025 01:15:07 PM
- Evaxion announce 2026 financial calendar • GlobeNewswire Inc. • 11/12/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/07/2025 10:30:11 PM
- Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 • GlobeNewswire Inc. • 11/07/2025 10:10:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2025 12:45:07 PM
- Evaxion announces business update and third quarter 2025 financial results • GlobeNewswire Inc. • 11/06/2025 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2025 02:15:09 PM
- Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate • GlobeNewswire Inc. • 11/03/2025 02:00:00 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 10/31/2025 01:49:33 PM
- Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 • GlobeNewswire Inc. • 10/31/2025 01:05:34 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/31/2025 12:15:05 PM
- Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025 • GlobeNewswire Inc. • 10/31/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2025 01:30:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2025 12:15:05 PM
- Evaxion raises $7.2 million, extending cash runway to second half of 2027 • GlobeNewswire Inc. • 10/30/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2025 12:15:05 PM
- Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation • PR Newswire (US) • 10/17/2025 01:50:00 PM
- Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation • PR Newswire (Canada) • 10/17/2025 01:50:00 PM
- Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation • PR Newswire (US) • 10/17/2025 01:50:00 PM
FEATURED I-ON Digital Corp. Deploys $200 Million in Assets Under Management (AUM), Backed By In Situ Gold Reserves, As I-ON's Treasury Solidifies Diversified Yield Strategies From Digital Asset Deployment • Dec 4, 2025 8:30 AM
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations • SNGX • Dec 4, 2025 10:18 AM
Metavesco Fast-Tracks OTC Prediction Market Platform • MVCO • Dec 3, 2025 9:12 AM
Scientists Pointing to Hidden Power Source That Could Reshape Future of AI • MAXXF • Dec 3, 2025 9:00 AM
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now • PFE • Dec 2, 2025 9:00 AM
Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order • BLO • Dec 2, 2025 8:50 AM
